New Strategies in Overcoming Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Ähnliche Einträge

• Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation
  von: Oxnard, Geoffrey R., et al.
  Veröffentlicht: (2010)
• Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib
  von: Oxnard, Geoffrey R., et al.
  Veröffentlicht: (2011)
• Strategies for Overcoming Resistance to EGFR Family Tyrosine Kinase Inhibitors
  von: Giaccone, Giuseppe, et al.
  Veröffentlicht: (2011)
• Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
  von: Yu, Helena A., et al.
  Veröffentlicht: (2013)
• Acquired Resistance to EGFR Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with EGFR-Mutant Lung Adenocarcinoma
  von: Bean, James, et al.
  Veröffentlicht: (2008)